SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing heightened volatility and sharp price swings as investors weigh the company's massive cloud backlog and AI infrastructure investments against broader market concerns over tech-sector valuations and debt. The community is actively debating whether recent pullbacks represent a temporary shakeout of retail investors ahead of highly anticipated earnings, or if the stock is being unfairly penalized by institutional rotation and broader macro-driven selling.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as shares rally following a surge in May prediction market volumes, fueling community debate over the platform's role in future growth. Investors remain divided, with bulls highlighting expansion into new states as a long-term catalyst, while vocal critics focus on the stock's recent performance and ongoing management concerns.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently trending due to active investor speculation surrounding potential buyout rumors and an aggressive share buyback program that continues to reduce the float. The community remains deeply divided, with many bulls highlighting the stock's low price-to-earnings multiple as a deep-value opportunity, while frustrated traders express ongoing concern over stagnant price action and the company's competitive positioning.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is capturing significant investor attention as the community debates its long-term potential in the MS market, focusing on the successful commercial launch of Briumvi and the strategic implications of upcoming subcutaneous dosing data. Discussions center on whether the company's growth trajectory and pipeline expansion make it a prime candidate for a high-premium buyout, or if management will continue building the business independently.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is trending as investors weigh strong institutional interest in its growing data center infrastructure against ongoing concerns regarding the CEO's communication strategy. While community members highlight the massive potential of the Helios campus, many are actively debating whether the stock is undervalued compared to its peers or if it remains held back by its heavy historical ties to crypto volatility.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as shares reach five-year highs following a significant patent extension for its lead drug, MIPLYFFA, through 2041. The community is actively discussing the company's strong fundamental position, analyst price target upgrades, and speculation regarding a potential buyout.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

iShares Silver Trust is experiencing significant volatility as market participants debate its role as a hedge against inflation and geopolitical uncertainty amid conflicting reports on international conflicts and aggressive selling pressure. The community remains deeply divided, with some investors aggressively accumulating on dips citing long-term industrial demand for electrification and AI, while others argue the metal is stuck in a corrective phase following a period of over-optimistic speculation.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWM is currently capturing investor attention as a structural outlier, holding steady at its gamma flip level while large-cap tech faces systematic repricing and heightened volatility. The market remains intensely focused on upcoming inflation data and potential Federal Reserve policy shifts, with traders closely debating whether the current rotation signals a rotation into small caps or a broader defensive positioning ahead of key macro catalysts.

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Casey's General Stores, Inc.

Casey's General Stores is seeing significant investor attention driven by strong earnings growth, aggressive store expansion plans, and its consistent performance in the retail sector. The community is actively debating the stock's valuation and long-term potential, with bulls pointing to its recession-proof business model and consistent pizza sales, while skeptics remain cautious about high multiples.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is experiencing a sharp sell-off following the Worldwide Developers Conference, as investors express disappointment over the company's AI strategy and Siri enhancements. While some analysts maintain a bullish outlook based on long-term product roadmaps and ecosystem monetization, the community is debating whether the lack of immediate innovation justifies the stock's current premium valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vyant Bio, Inc. is a biotechnology company, which engages in drug discovery for complex neurodevelopmental and neurodegenerative disorders. The firm's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. Its programs are focused on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome, CDKL5 Deficiency Disorders, and familial Parkinson's Disease. The company was founded on April 8, 1999 and is headquartered in Cherry Hill, NJ.

Current Price	$0.194
Prev Close	$0.18
Open	$0.18
Dividend Yield	N/A
50-Day Moving Average	$0.1755
Beta	0.64
Avg. Volume	10,128.67
PE Ratio	-0.09

52-Week High	$1.58
52-Week Low	$0.141
Market Capitalization	$1.23M
EPS (Annual)	N/A
Price to Book	0.27
Revenue Per Employee	N/A

VYNTVyant Bio Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VYNT News